Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont... Show more
Corteva, Inc. holds market-leading positions in both seeds and crop protection, with brands like Pioneer commanding significant share in corn and soybeans alongside competitors such as Bayer. The company derives roughly 56% of sales from seeds and 44% from crop protection, benefiting from a historically integrated model that has driven innovation in biotechnology and sustainable solutions. The forthcoming separation will allow each entity to pursue specialized strategies: SpinCo emphasizing R&D in advanced genetics and gene editing, while New Corteva focuses on biologicals, supply chain optimization, and disciplined M&A (mergers and acquisitions). This evolution addresses diverging market dynamics, enhancing competitive edges through targeted investments and partnerships. Medium-term, Corteva's elite breeding programs and premium product portfolio support resilient market share amid global demand for higher yields.
The Q1 2026 earnings on May 5 represent a pivotal near-term event, where management may affirm FY2026 guidance (consensus EPS $3.66, revenue $18.08 billion) and share spin-off milestones, including leadership transitions announced in April. Progress toward the H2 2026 separation—on track for Q4—could catalyze re-rating as investors price in unlocked value from focused entities. Investor Days on September 15, 2026, for SpinCo will outline independent growth plans, potentially driving analyst revisions. Recent price target hikes (e.g., Oppenheimer to $89, Rothschild to $90) reflect optimism around innovation launches in herbicide-tolerant traits and fungicides. Consensus remains overweight, with stable FY2026 estimates signaling steady sentiment, though downside risks from earnings misses could prompt caution.
The agriculture sector faces a challenging 2026 with projected lower commodity prices—corn at $4.62/bushel, soybeans $11.09—squeezing farmer margins and crop input spending. Corteva's business model, tied to seeds and crop protection, exhibits sensitivity to these trends, as reduced farm incomes may favor premium, high-return products over volumes. Stabilizing input costs and moderating inflation could ease pressure, while geopolitical stability supports trade flows critical for Latin American volumes. Rising technology adoption in precision ag and biologicals aligns with regulatory pushes for sustainability, bolstering Corteva's pipeline. Interest rate trajectories will influence capital costs for R&D-intensive expansion.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. It is designed to spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments. The product includes searchable prediction categories, historical context, and alert-oriented functionality to enhance decision-making. Users can leverage this resource to stay ahead of market shifts.
Post-separation in H2 2026, both entities are positioned for optimized operations: SpinCo targeting growth via gene editing, hybrid wheat, and biofuels licensing; New Corteva prioritizing margin expansion through biologicals and supply efficiencies. Consensus FY2026 estimates project 9.47% EPS growth, underpinned by $18 billion+ revenue, with long-term drivers including global food demand, climate-resilient traits, and cost discipline. Key themes include regulatory approvals for biotech innovations, competitive M&A in fragmented markets, and adaptation to volatile weather patterns. Analyst expectations, with overweight consensus and $86 average target, hinge on execution amid persistent ag headwinds; sustained R&D investment (elite breeding, digital tools) will be crucial for margin sustainability beyond 2026.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a holding company, which engages in the provision of agricultural products.
Industry ChemicalsAgricultural
A.I.dvisor indicates that over the last year, CTVA has been loosely correlated with NTR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CTVA jumps, then NTR could also see price increases.
| Ticker / NAME | Correlation To CTVA | 1D Price Change % | ||
|---|---|---|---|---|
| CTVA | 100% | +1.71% | ||
| NTR - CTVA | 46% Loosely correlated | +3.14% | ||
| MOS - CTVA | 43% Loosely correlated | +7.59% | ||
| IPI - CTVA | 38% Loosely correlated | +5.21% | ||
| FMC - CTVA | 37% Loosely correlated | +5.15% | ||
| CF - CTVA | 36% Loosely correlated | +2.74% | ||
More | ||||
CTVA saw its Momentum Indicator move below the 0 level on May 18, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 82 similar instances where the indicator turned negative. In of the 82 cases, the stock moved further down in the following days. The odds of a decline are at .
The Moving Average Convergence Divergence Histogram (MACD) for CTVA turned negative on May 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .
CTVA moved below its 50-day moving average on May 18, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CTVA crossed bearishly below the 50-day moving average on May 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 21 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTVA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for CTVA entered a downward trend on June 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CTVA's RSI Oscillator exited the oversold zone, of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CTVA advanced for three days, in of 339 cases, the price rose further within the following month. The odds of a continued upward trend are .
CTVA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.090) is normal, around the industry mean (1.370). P/E Ratio (41.157) is within average values for comparable stocks, (46.690). Projected Growth (PEG Ratio) (1.282) is also within normal values, averaging (1.625). Dividend Yield (0.009) settles around the average of (0.045) among similar stocks. CTVA's P/S Ratio (2.886) is slightly higher than the industry average of (1.419).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CTVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.